Drug use and nephrotoxicity in the intensive care unit

Kidney International

Volumn 81, Issue 12, 2012, Pages 1172-1178

  Perazella, Mark A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; chronic kidney disease; drugs; intensive care unit; pharmacokinetics; volume of distribution

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; BETA LACTAM; CALCINEURIN INHIBITOR; CIPROFLOXACIN; CONTRAST MEDIUM; CYCLOSPORIN; HETASTARCH; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; RENIN INHIBITOR; SODIUM DIHYDROGEN PHOSPHATE; TACROLIMUS;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG RESPONSE; DRUG USE; HEART FAILURE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; NEPHROSIS; NEPHROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK;

EID: 84861692516     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.475     Document Type: Article

References (41)

1. Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010; 38: 261-275.
2. Uchino S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006; 12: 538-543. (Pubitemid 44673428)
3. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007; 11: R68.
4. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818. (Pubitemid 41175724)
5. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917. (Pubitemid 43982467)
6. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370. (Pubitemid 46179340)
7. Joannidis M, Druml W, Forni LG et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Intensive Care Med 2010; 36: 392-411.
8. Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66: 1613-1621. (Pubitemid 39298397)
9. Taber SS, Mueller BA. Drug-associated renal dysfunction. Crit Care Clin 2006; 22: 357-374. (Pubitemid 44308117)
10. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients. Crit Care 2006; 10: R73.
11. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35: 1837-1843. (Pubitemid 47220356)
12. Bagshaw SM, Uchino S, Bellomo R et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2: 431-439.
13. Kapoor JR, Perazella MA. Diagnostic and therapeutic approach to acute decompensated heart failure. Am J Med 2007; 120: 121-127. (Pubitemid 46175783)
14. Ronco C. Cardiorenal syndromes: definition and classification. Contrib Nephrol 2010; 164: 33-38.
15. Mullens W, Abrahams Z, Francis GS et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589-596.
16. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-1290.
17. Schrier RW. Decreased effective blood volume in edamatous disorders: what does this mean? J Am Soc Nephrol 2007; 18: 2028-2031. (Pubitemid 47041067)
18. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 48: 2064-2077.
19. Fisher EM, Brown DK. Hepatorenal syndrome: beyond liver failure. Adv Crit Care 2010; 21: 165-186.
20. Olyaei AJ, Bennett WM. Drug dosing in the elderly patients with chronic kidney disease. Clin Geriatr Med 2009; 25: 459-527.
21. Dreisbach AW. The influence of chronic renal failure on drug metabolism and transport. Clin Pharmacol Ther 2009; 86: 553-556.
22. Nolin TD, Naud J, Leblond FA et al. Emerging evidence of the impact of kidney disease on drug metabolism and transport. Clin Pharmacol Ther 2008; 83: 898-903. (Pubitemid 351704931)
23. Benoit DD, Hoste EA. Acute kidney injury in critically ill patients with cancer. Crit Care Clin 2010; 26: 151-179.
24. Sahni V, Choudhury D, Ahmed Z. Chemotherapy-associated renal dysfunction. Nat Rev Nephrol 2009; 5: 450-462.
25. Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin 2006; 22: 255-271.
26. Vilay AM, Churchwell MD, Mueller BA. Drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 2008; 12: 235-243.
27. Schmith VD, Foss JF. Inflammation: planning for a source of pharmacokinetic/pharmacodynamic variability in translational studies. Clin Pharmacol Ther 2010; 87: 488-491.
28. Chan LMS, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: efflux protein limiting drug absorption and bioavailability. Eur J Pharmaceut Sci 2004; 21: 25-51. (Pubitemid 38050202)
29. Leung N, Eirin A, Irazabal MV et al. Acute kidney injury in patients with inactive cytochrome P450 polymorphisms. Ren Fail 2009; 31: 749-752.
30. Doi K, Yuen PST, Eisner C et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20: 1217-1221.
31. Schetz M. Drug dosing in continuous renal replacement therapy: general rules. Curr Opin Crit Care 2007; 13: 645-651. (Pubitemid 350059527)
32. Swan SK, Bennett WM. Drug dosing guidelines in patients with renal failure. West J Med 1992; 156: 633-638.
33. Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 2009; 65: 757-773.
34. Rosner MH, Okusa MD. Drug-associated acute kidney injury in the intensive care unit. In: DeBroe M, Porter G, Bennett W, Deray G (eds). Clinical Nephrotoxins-Renal Injury from Drugs and Chemicals, 3rd edn. Springer: New York, NY, 2008, pp 29-41.
35. Lamiere N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Rev Nephrol 2006; 2: 364-377. (Pubitemid 44034187)
36. Schetz M, Dasta J, Goldstein S et al. Drug-induced acute kidney injury. Curr Opin Crit Care 2005; 11: 555-565. (Pubitemid 41697327)
37. Perazella MA. Drug-induced nephropathy: an update. Expert Opin Drug Saf 2005; 4: 689-706. (Pubitemid 40946067)
38. Nolin TD, Himmelfarb J. Mechanisms of drug-induced nephrotoxicity. Adv Drug reactions 2010; 196: 111-130.
39. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta 2005; 351: 31-47. (Pubitemid 39563555)
40. Schortgen F, Brochard L. Colloid-induced kidney injury: experimental evidence may help understand mechanisms. Crit Care 2009; 13: 130-131.
41. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010; 6: 461-470.